概括
儿科骨髓增殖性瘤 (MPNs) 呈现出独特的遗传特征. 下一代测序显示,在儿童的基本血小板血 (ET) 中,驱动突变较少,在初级骨髓纤维化 (PMF) 中,多个非驱动突变较少.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 骨髓增殖性瘤 (MPNs) 是血液造血干细胞的罕见克隆性疾病.
- 儿科MPN,包括基本血小板血 (ET) 和原发性骨髓纤维化 (PMF),遗传和生物学理解有限.
- 下一代测序 (NGS) 提供了一个强大的工具来研究儿科MPNs的遗传景观.
研究的目的:
- 使用NGS识别和描述儿科MPN的遗传变异.
- 探索儿科和成人MPN之间的遗传差异.
- 评估儿科MPN患者中发现的遗传变异的临床意义.
主要方法:
- 包括9名2000年至2023年间诊断的儿科患者 (8 ET,1 PMF).
- 骨髓吸附样本使用下一代测序 (NGS) 在Ion S5 XL测序仪上进行分析.
- 对于全面的遗传变异检测,使用了OncomineTM骨髓质研究试验.
主要成果:
- 在56%的儿科MPN患者中发现了临床显著的遗传变异.
- 两名ET患者携带了JAK2 V617F驱动器突变;另外两名患者有FLT3和ETV6变异.
- 单个PMF患者在8个基因中表现出10个变异,包括BCOR,TET2和ZRSR2.2中的新突变.
结论:
- 与成人形式相比,儿科MPNs具有独特的遗传特征.
- 儿科ET显示,常见的驱动器突变的发生率较低.
- 儿科PMF的特点是多种非驱动型变体,可能表明预后较差.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.0K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.3K
相关概念视频
Comparing Copy Number Variations and SNPs
17.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
Next-generation Sequencing
92.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
92.7K
